Matthew Kaplan - Jun 13, 2024 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Director
Signature
/s/ Matthew Kaplan
Stock symbol
NVCT
Transactions as of
Jun 13, 2024
Transactions value $
$0
Form type
4
Date filed
6/13/2024, 04:22 PM
Previous filing
Jun 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Award $0 +30K +55.8% $0.00 83.8K Jun 13, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The 30,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Kaplan's continued service on the board on such dates.